RxDoctor Payments Data

James Melville

Oral and Maxillofacial Surgery · Houston, TXNPI 1972751907

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $151,950 of the $239,281 with a category attached, or 63.5%. 19 manufacturers reported payments, led by Axogen at 59.5% of the total. 2025 is the largest year on record at $73,667, 2.4 times the $30,505 reported in 2019. Among oral and maxillofacial surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$239,281in general payments, 2019–2025

Across 408 payments — averaging $586.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axogen$142K
  • Kerecis Limited$82K
  • Kls-martin L.p.$7K
  • Medical Device Business Services, Inc.$3K
  • Acell, Inc.$2K
  • Checkpoint Surgical, Inc$440
  • plus $2K from 13 others
$2,470in research payments, 2019–2025

Across 1 payment — averaging $2470.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sonavex, Inc.$2K

What the payments were for

  • Consulting fees$36,29115%
  • Speaking & faculty fees$151,95064%
  • Travel & lodging$17,2317%
  • Food & beverage$26,30911%
  • Education$7,5003%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$239,281 in reported general payments places this provider in the 95th percentile of 591 oral and maxillofacial surgery providers in Texas.

See all oral and maxillofacial surgery providers in Texas

Medicare billing

Part B allowed, 2024
$4,889
Medicare patients
20
Services billed
40

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pentoxifylline31$792
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav18$384
Doxycycline Hyclate26$250
Metronidazole18$140
Chlorhexidine Gluconate32$105
Amoxicillin14$33

Paid to pharmacies, not to this prescriber.

Other oral and maxillofacial surgery in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →